Navigation Links


CRF1 in Medical News

Neurocrine Biosciences Reports Fourth Quarter and Year-End 2008 Results

...ue high affinity and selective antagonists for the crf1 receptor that are currently in clinical developmen...e study to evaluate the safety and efficacy of the crf1 receptor antagonist, 876008, in approximately 130 ...8 and placebo. GSK has advanced a novel lead crf1 receptor antagonist compound, 561679, into a Phase...
CRF1 in Medical Technology

Neurocrine Biosciences Reports First Quarter 2008 Results

...ailable in the second half of 2008. GSK is also advancing the second lead crf1 receptor antagonist, 561679, into a Phase II major depression disorder study in the middle of this year. GSK has also moved a third crf1 compound, 586529, into a Phase I single dose escalating clinical trial. U...

Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results

...e II "proof of concept" clinical trial with a lead crf1 receptor antagonist compound, 876008, for SocAD an...e study to evaluate the safety and efficacy of the crf1 receptor antagonist compound in patients with SocA...d half of 2008. GSK is advancing the second lead crf1 receptor antagonist, 561679, into a Phase II depre...
CRF1 in Biological Technology

Development of a CRF1 neuropeptide receptor binding assay using LEADseeker Multimodality Imaging System

Key words: CRF 1 • GPCR • receptor binding assay • LEADseeker • SPA Imaging Beads In the mammalian brain, the corticotrophin-releasing factor (CRF) system comprises four CRF-related peptides (CRF and urocortin 1, 2, and 3...

Neurocrine Biosciences Reports First Quarter 2009 Results

...ue high affinity and selective antagonists for the crf1 receptor that are currently in clinical developmen...ood disorders. GSK has advanced a novel lead crf1 receptor antagonist compound, 561679, into a Phase... dose-escalating clinical trial with an additional crf1 compound, 586529, for the treatment of anxiety and...

Neurocrine Biosciences Reports Third Quarter 2008 Results

...ble later in 2008. GSK has advanced a novel lead crf1 receptor antagonist compound, 561679, into a Phase...single dose-escalating clinical trial with a third crf1 compound, 586529, for the treatment of anxiety and...itable for further clinical studies; risk that the crf1 receptor antagonist candidate's Phase II proof of ...

Neurocrine Biosciences Reports Second Quarter 2008 Results

...of 2008. GSK will soon be advancing a novel lead crf1 receptor antagonist compound, 561679, into a Phase...single dose-escalating clinical trial with a third crf1 compound, 586529, for the treatment of anxiety and...itable for further clinical studies; risk that the crf1 receptor antagonist candidate's Phase II proof of ...
Other TagsROIROIROIROIROIROIaxeaxeaxe
(Date:11/9/2009)... Tomorrow may be too late when it ...ion, according to TOPS Club, Inc. (Take Off Pounds...nization. , (Vocus) Novem...mes to preventing or improving a diabetes conditio...ensibly), the nonprofit weight-loss support organi...
(Date:11/9/2009)... New study highlights positive inf... Rosemont, IL (Vocus) Novemb... bone health decreases. Recent research has highli...ements to help prevent these issues. However, a ne...f Sports Health: A Multidisciplinary Approach re...
(Date:11/9/2009)...TA MONICA, Calif., Nov. 9 Actress ... joined philosophy on Saturday to raise awar... services throughout California by building healin... Enough kits were created to give one to each of t...ne of Los Angeles County,s domestic violence shelt...
(Date:11/9/2009)...arch of Dimes Names 2010 National Ambassador ,...re/ -- Joshua Hoffman of Weston, Fla., was born so... doctors could not say whether he would survive --...y, the 6-year-old was named March of Dimes 2010 Na...ffman, recalls, "My first minutes of motherhood an...
(Date:11/9/2009)...ROIT, Nov. 9 For the th...cer Center has been selected the most preferred ho...rding to a survey by the National Research Corpora...in/prnh/20071106/KARMANOSLOGO ) ,, The annual ...e between September 2008 and August 2009. Survey r...
Breaking Medicine News(10 mins):Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 2Health News:Diabetes Prevention Is the Best Remedy, TOPS Medical Expert Says 3Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 2Health News:Actress Mariska Hargitay and the Joyful Heart Foundation Join philosophy to Serve Women in Crisis Throughout Los Angeles County 3Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 2Health News:Six-Year-Old Survivor Fights for Preemies Like Himself 3Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2
(Date:11/5/2009)...hers (NABT) will recognize Leonard C. Yannielli, p...y Community College (NVCC) in Waterbury, Connectic... the NABT annual professional development conferen...ado. , The Evolution Education Award is cosponso...es,(AIBS) and Biological Sciences Curriculum Stud...
(Date:11/4/2009)...luctant to officially endorse green tea as a cance...out its protective effects, including results of a...h , a journal of the American Association for Canc... cancer. , Vassiliki Papadimitrakopoulo, M.D., ...c/Head and Neck Medical Oncology at the University...
(Date:11/4/2009)...od obesity in the United States is reaching epidem...tising on daytime and prime time television devote...about the role television plays in obesity, a stud...f Nutrition Education and Behavior examines how f... contributor to the problem. , Researchers at th...
Breaking Biology News(10 mins):Biologists, educators recognize excellence in evolution education 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 1Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 2Viral Genetics Scientist Presents Potential New Treatment for Drug Resistant Brain Tumors at Aspen Symposium 13511 3VIVUS Reports Second Quarter 2009 Financial Results 54258 1VIVUS Reports Second Quarter 2009 Financial Results 54258 2VIVUS Reports Second Quarter 2009 Financial Results 54258 3VIVUS Reports Second Quarter 2009 Financial Results 54258 4VIVUS Reports Second Quarter 2009 Financial Results 54258 5VIVUS Reports Second Quarter 2009 Financial Results 54258 6VIVUS Reports Second Quarter 2009 Financial Results 54258 7Ohio Judge Rules Tobacco Settlement Funds Should Be Used as Intended to Reduce Tobacco Use and Save Lives 54255 1Ohio Judge Rules Tobacco Settlement Funds Should Be Used as Intended to Reduce Tobacco Use and Save Lives 54255 2
Other Contentslethargylethargyleukoplakialeukopenialigamentligamentligamentligamentplanuslilylightening